Table 3.
Predictors for death within 30 days after intervention
Alive 30 days |
Alive < 30 days | p-value | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 106 | n = 21 | ||||||||||||
| Baseline Characteristics | |||||||||||||
Age 65 years |
64 (60.4%) | 10 (47.6%) | 0.3 | ||||||||||
BMI 18.5 |
10 (9.4%) | 5 (23.8%) | 0.06 | ||||||||||
CCI 8 |
52 (49.1%) | 14 (66.7%) | 0.1 | ||||||||||
| Female Sex | 51 (48.1%) | 14 (66.7%) | 0.1 | ||||||||||
| Primary Lung Tumours | 82 (77.4%) | 14 (66.7%) | 0.3 | ||||||||||
| Preoperative ASA III | 51 (48.1%) | 8 (38.1%) | 0.4 | ||||||||||
| Current or Previous Smoker | 82 (77.4%) | 17 (81.0%) | 0.7 | ||||||||||
| Respiratory Support Needed | 35 (33.0%) | 15 (71.4%) | 0.001 | ||||||||||
| Non-invasive Tumour Growth | 14 (13.2%) | 5 (23.8%) | 0.2 | ||||||||||
| Index Intervention | |||||||||||||
| Stent Insertion | 59 (55.7%) | 17 (81.0%) | 0.03 | ||||||||||
| Urgent or Semi-urgent | 69 (65.1%) | 16 (76.2%) | 0.3 | ||||||||||
| Level of Stenosis | |||||||||||||
| Tracheal | 13 (12.3%) | 6 (28.6%) | 0.06 | ||||||||||
| Tracheobronchial | 20 18.9% | 6 (28.6%) | 0.3 | ||||||||||
| Unilateral bronchi | 64 (60.4%) | 5 (23.8%) | 0.008 | ||||||||||
| Bilateral bronchi | 9 (8.5%) | 4 (19.1%) | 0.2 | ||||||||||
| Oncological Treatment after Intervention | |||||||||||||
| Chemoradiotherapy | 59 (55.7%) | 3 (14.3%) | < 0.001 | ||||||||||
| Immunotherapy | 12 (11.3%) | 0 (0.0%) | 0.1 | ||||||||||



